Brighthouse Financial (BHF) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
26 Dec, 2025Executive summary
Record Shield Level Annuities sales reached $7.7B, up 12% YoY, and life insurance sales hit $120M, up 18% YoY, with total annuity sales of $10B in 2024.
Entered the worksite channel with BlackRock's LifePath Paycheck, now live in six employer plans with $16B AUM.
Corporate expenses decreased by over 7% year-over-year, reflecting ongoing expense discipline.
Net income available to shareholders for Q4 2024 was $646M ($10.79 per share), reversing a $942M loss in Q4 2023.
Repurchased $250M of common stock in 2024, reducing shares outstanding by 8%; an additional $25M repurchased through February 7, 2025.
Financial highlights
Q4 2024 adjusted earnings, less notable items, were $352M ($5.88 per share), up from $189M ($2.92 per share) in Q4 2023.
Adjusted Q4 earnings were $304M, including a $48M unfavorable notable item; excluding this, adjusted earnings were $352M.
Book value at Q4 2024 was $3.3B ($55.60 per share); book value excluding AOCI was $8.5B ($145.63 per share).
Net investment income for Q4 2024 was $1,373M; adjusted net investment income yield was 4.51%.
Statutory combined total adjusted capital was ~$5.4B; estimated combined RBC ratio was ~400%.
Outlook and guidance
Combined RBC ratio expected to remain stable over the next few years without further holding company support, assuming normal markets.
Financial plan contemplates taking dividends from operating companies after 2024.
Management expects continued volatility in net income due to differences between hedge targets and GAAP reserves.
Focus remains on executing capital-focused initiatives and maintaining expense discipline in 2025.
Strategic focus remains on capital management, cost control, and product innovation.
Latest events from Brighthouse Financial
- Q4 net income declined, but record annuity and life sales and a pending $4.1B acquisition marked 2025.BHF
Q4 202523 Feb 2026 - Merger and related proposals were approved by stockholders as recommended by the board.BHF
EGM 202612 Feb 2026 - Shareholders to vote on merger amid litigation and board's unanimous support.BHF
Proxy Filing4 Feb 2026 - Adjusted earnings reached $346M with record life sales, but statutory capital and RBC ratio declined.BHF
Q2 20242 Feb 2026 - Adjusted earnings surged on actuarial gains, with life sales up 19% and capital actions ongoing.BHF
Q3 202415 Jan 2026 - Shareholders to vote on $70/share cash merger with Aquarian Holdings; board recommends approval.BHF
Proxy Filing7 Jan 2026 - Shareholders to vote on $70.00 per share cash merger, with board unanimous in recommending approval.BHF
Proxy Filing23 Dec 2025 - Preliminary proxy outlines annual meeting proposals and board governance for shareholder vote.BHF
Proxy Filing1 Dec 2025 - Shareholders to vote on directors, auditor, executive pay, and updated incentive plan amid strong strategic progress.BHF
Proxy Filing1 Dec 2025